Published in Lab Business Week, May 21st, 2006
Trading on the TSX commenced on April 18, 2006, at the market opening under the symbol "BMR."
"We believe the transition to the TSX from the TSX Venture reflects the maturity of Bradmer's lead product candidate Neuradiab. This transition is in keeping with our strategy to advance the corporate progress of the company by broadening the base of potential investors to support our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.